Citius Pharmaceuticals, Inc. SEC filings CTXR
Citius Pharmaceuticals, Inc. has 638 filings in SEC EDGAR's recent list, going back to Nov 23, 2010. Its latest annual report, Form ARS, was filed on Feb 24, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Feb 24, 2026 | — |
| DEF 14A | Proxy statement | Feb 24, 2026 | Apr 6, 2026 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 9, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Apr 18, 2025 |
| DEFA14A | Additional proxy material | Jan 27, 2025 | — |
| DEF 14A | Proxy statement | Jan 27, 2025 | Mar 10, 2025 |
| PRE 14A | Preliminary proxy statement | Jan 16, 2025 | Jan 10, 2025 |
| DEFA14A | Additional proxy material | Jan 26, 2024 | — |
| DEF 14A | Proxy statement | Jan 26, 2024 | Mar 12, 2024 |
| DEFA14A | Additional proxy material | Dec 22, 2022 | — |
| DEF 14A | Proxy statement | Dec 22, 2022 | Feb 7, 2023 |
| DEFA14A | Additional proxy material | Dec 20, 2021 | — |
| DEF 14A | Proxy statement | Dec 20, 2021 | Feb 8, 2022 |
| DEFA14A | Additional proxy material | May 28, 2021 | — |
| DEFA14A | Additional proxy material | Apr 12, 2021 | — |
| DEF 14A | Proxy statement | Apr 12, 2021 | May 24, 2021 |
| PRE 14A | Preliminary proxy statement | Mar 12, 2021 | Mar 12, 2021 |
| DEFA14A | Additional proxy material | Dec 21, 2020 | — |
| DEF 14A | Proxy statement | Dec 21, 2020 | Feb 9, 2021 |
| DEF 14A | Proxy statement | Dec 20, 2019 | Feb 10, 2020 |
| DEFA14A | Additional proxy material | Dec 20, 2019 | — |
| DEF 14A | Proxy statement | Dec 20, 2018 | Feb 13, 2019 |
| DEF 14A | Proxy statement | Dec 13, 2017 | Feb 7, 2018 |
| DEF 14A | Proxy statement | Aug 11, 2016 | Sep 15, 2016 |
| PRE 14A | Preliminary proxy statement | Jul 1, 2016 | Jul 1, 2016 |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CTXR (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- NV
- Headquarters
- Cranford, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1506251
- Former names
- Trail One, Inc. (until Sep 18, 2014); TrailOne, Inc. (until Jan 21, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.